Weekly SCD Practice Update

Study Finds Specific Biomarkers to Predict Sickle Cell Anemia Disease Severity

Key Findings

  • Purpose To identify hematological, biochemical, and metabolic biomarkers associated with sickle cell anemia (SCA) severity and to assess machine learning models’ ability to predict disease severity accurately.
  • Population 481 participants were enrolled at Korle-Bu Teaching Hospital in Ghana, including 356 with SCA and 125 healthy controls.
  • Headline Result Strong correlations emerged between immune cell counts, red cell indices, and bilirubin, reflecting inflammation and hemolysis in SCA. Five biomarkers: direct bilirubin, total bilirubin, reticulocyte count, hydrogen sulfide, and neutrophil count ranked as the most predictive of severity.
  • Why It Matters These findings offer a data-driven method to stratify patients by severity using routine biomarkers and machine learning in SCA.
  • Evidence Gaps The study was limited to a single-center Ghanaian cohort; the sample size, while meeting minimum requirements for machine learning, limits generalizability. The limited range of hematological biomarkers used did not fully explain inter-group variability, suggesting the need for broader panels that include radiological, laboratory, and clinical markers.
Source: Journal of Sickle Cell Disease – Identification of Hematological Biomarkers and Assessment of Machine Learning Models for Sickle Cell Anemia Severity Classification

Stay Informed. Stay Empowered.

Subscribe to our newsletter for the latest updates on sickle cell research, events, and resources.

Get expert insights, patient stories, and ways to get involved, delivered straight to your inbox.

Join our community today!